I found a card from him the other day and my breath hitched. Then I remembered how annoying I thought he was the first time I heard him.

Driven by the reignited Cancer Moonshot, the National Cancer Institute (NCI) hosted a virtual roundtable discussion on the possibilities and challenges of increasing clinical trial accrual in May 2022.  

Creating a pathway for policymakers, providers, and the public to understand and recommend a new professional nursing dynamic, the Institute of Medicine’s 2011 Future of Nursing report investigated the current and future state and challenges of the nursing profession.

Highlighting the most prominent barriers that people accessing care face and the influencers acting on providers, the Centers for Medicare and Medicaid Services (CMS) unveiled in May Chronic Pain Experience Journey Map. The map came out of the work done under the 2019 Chronic Pain Stakeholder Engagement initiative to explore the serious role chronic pain has in patients’ lives.  

Patients with higher levels of digital health literacy have more positive survival outcomes during cancer, researchers reported in study findings published in JCO Clinical Cancer Informatics.

ONS honored a long-time member, Margaret Hansen Frogge, MS, RN, for a career of contributions to cancer care with its 2022 ONS Lifetime Achievement Award during the 47th Annual ONS Congress® in Anaheim, CA. The award commemorates Frogge’s passion for the profession through decades of oncology nursing practice and leadership. 

In a fitting tribute to a life that touched so many others, ONS honored member Catherine Lyons, RN, MS, NEA-BC, FNAP, posthumously with a 2022 ONS Lifetime Achievement Award during its 47th Annual ONS Congress® in Anaheim, CA. Before her retirement and death in November 2021, Lyons was an executive consultant for oncology services. 

The Palliative Care and Hospice Education and Training Act (PCHETA), an ONS health policy priority that supports both patients and the profession, returned to the U.S. Senate floor in May 2022. Senators Tammy Baldwin (D-WI) and Shelley Moore Capito (R-WV) reintroduced the bill to improve and sustain the workforce and the well-being of patients and their families with life-threatening illnesses.  

With so many of today’s cancer treatments administered orally, ensuring that patients adhere to their regimen as prescribed is essential to optimal outcomes. According to the World Health Organization, medication adherence is the single most important modifiable factor that affects treatment outcomes.

The U.S. Food and Drug Administration (FDA) proposed two product standards in April 2022 aimed at banning flavored tobacco and menthol products. According to FDA, the proposed product standard would “reduce the appeal of cigarettes, particularly to youth and young adults, and thereby decrease the likelihood that nonusers who would otherwise experiment with menthol cigarettes would progress to regular smoking.”